期刊文献+

慢性肾脏病非糖尿病非透析患者动脉僵硬度及其相关因素 被引量:5

Arterial stiffness and associated factors in non-diabetic pre-dialysis patients with chronic kidney disease
原文传递
导出
摘要 目的研究慢性肾脏病(CKD)3~5期非透析非糖尿病患者的动脉僵硬度,并探讨相关影响因素。方法采用Complior SP脉搏波速度(PWV)测定仪测定CKD患者颈动脉.股动脉PWV(CFPWV)。用多部位X线平片检测血管钙化情况。常规检测血压、相关血生化指标和全段甲状旁腺素(iPTH)水平。多元逐步回归方法分析影响PWV的因素。30例性别、年龄匹配的健康成人作为对照,检测CFPWV。结果入选患者96例,平均年龄(53.7±14.2)岁。CKD3、4、5期患者分别为32例、30例和34例,其CFPWV分别为(11.63±2.39)m/s、(11.70±2.80)m/s、(12.88±2.49)m/s,均高于健康对照(9.70±1.66)m/s(P〈0.05)。多元逐步回归分析结果显示,年龄、平均动脉压、血管钙化和iPTH是CFPWV的独立影响因素。结论CKD非糖尿病非透析患者大动脉僵硬度显著增加。年龄、平均动脉压、血管钙化和iPTH是CFPWV的独立影响因素。 Objective To study the arterial stiffness in non-diabetic pre-dialysis chronic kidney disease (CKD) patients and to explore the associated factors. Methods Automatic pulse wave velocity (PWV) measuring system was used to examine carotid-femoral pulse wave velocity (CFPWV) as the parameters reflecting central elastic large arterial elasticity. Vascular calcification was quantitatively evaluated by plain radiographic film of abdomen, pelvis and hands. Blood pressure, biochemical parameters and intact parathyroid hormone (iPTH) were routinely detected. Stepwise multiple linear regression analysis was used to assess the associated factors of arterial stiffness. Results Ninety-six non-diabetic pre-dialysis CKD patients and 30 healthy people were enrolled in this trial. CFPWV in stage 3, 4 and 5 CKD patients was significantly higher than that in healthy controls [(11.63±2.39) m/s, (11.70±2.80) m/s, (12.88±2.49) m/s vs (9.70±1.66)m/s , all P〈0.05]. Stepwise muhiple regression analysis demonstrated that age, mean arterial pressure, vascular calcification and iPTH were independent impact factors of CFPWV. Conclusions Arterial stiffness of large artery increases in non-diabetic pre-dialysis CKD patients. Age, mean arterial pressure, vascular calcification and iPTH are independent impact factors of CFPWV.
出处 《中华肾脏病杂志》 CAS CSCD 北大核心 2009年第4期277-281,共5页 Chinese Journal of Nephrology
关键词 肾疾病 肾功能不全 慢性 动脉硬化 非透析非糖尿病 脉搏波速度 动脉钙化 Kidney dialysis Pulse wave velocity disease Kidney insufficiency, chronic Non-diabetic pre- Vascular calcification
  • 相关文献

参考文献19

  • 1Foley RN, Parfrey PS, Samak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998, 32(5 Suppl 3): S112-S119.
  • 2Blacher J, Guerin AP, Pannier B, et al. Impact of aortic stiffness on survival in end-stage renal disease. Circulation, 1999, 99: 2434-2439.
  • 3Safar ME, Henry O, Meaume S. Aortic pulse wave velocity: an independent marker of cardiovascular risk. Am J Geriatr Cardiol, 2002, 11: 295-298.
  • 4Adragao T, Pires A, Lucas C, et al. A simple vascular calcification predicts cardiovascular risk in hemodialysis patients. Nephrol Dial Transplant 2004, 19: 1480-1488.
  • 5Covie A, Goldsmith DJ, Florea L, et al. The influence of dialytic modality on arterial stiffness, pulse wave reflections, and vasomotor function. Perit Dial Int, 2004, 24: 365-372.
  • 6Stompor between chronic dialysis. T, Rajzer M, Sulowicz W, et al. An association aortic pulse wave velocity, blood pressure and inflammation in ESRD patients on peritoneal Int J Artif Organs, 2003, 26: 188-195.
  • 7Haydar AA, Covie A, Colhoun H, et al. Coronary artery calcification and aortic pulse wave velocity in chronic kidney disease patients. Kidney Int, 2004, 65: 1790-1794.
  • 8Aoun S, Blacher J, Safar M, et al. Diabetes mellitus and renal failure: effects on large artery stiffness. J Hum Hypertens, 2001, 15: 693-700.
  • 9Shoji T, Emoto M, Shinohara K, et al. Diabetes mellitus, aortic stiffness, and cardiovascular mortality in end-stage renal disease. J Am Soc Nephrol, 2001, 12: 2117-2124.
  • 10甘良英,王梅.血液透析患者的动脉僵硬度及相关因素[J].中华肾脏病杂志,2008,24(4):245-248. 被引量:13

二级参考文献16

  • 1华琦,谭静,刘东霞,闻静,邢绣荣.高血压病患者颈-股动脉和颈-桡动脉脉搏波速度改变及其影响因素[J].中华心血管病杂志,2005,33(12):1088-1091. 被引量:41
  • 2唐利军,陈慧敏,程李涛,顾玥,汪涛.持续性非卧床腹膜透析患者容量超负荷与大动脉僵硬度的关系[J].中华肾脏病杂志,2007,23(2):106-109. 被引量:16
  • 3Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis, 1998,32(5 Suppl 3):S112-S119.
  • 4Ganesh SK, Stack AG, Levin NW, et al. Association of elevated serum PO(4), Ca×PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol, 2001,12:2131-2138.
  • 5Locatelli F, Cannata-Andia JB, Drueke TB, et al. Management of disturbances of calcium and phosphate metabolism in chronic renal insufficiency, with emphasis on the control of hyperphosphataemia. Nephrol Dial Transplant, 2002, 17:723-731.
  • 6Blacher J, Guerin AP, Pannier B, et al. Impact of aortic stiffness on survival in end-stage renal disease. Circulation, 1999,99:2434-2439.
  • 7Covic A, Gusbeth-Tatornir P, Goldsmith D J, Arterial stiffness in renal patients: an update. Am J Kidney Dis, 2005,45:965 -977.
  • 8Moe S, Drueke T, Cunningharn J, et al, Definition,evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outconles (KDIGO). Kidney Int, 2006,69:1945-1953.
  • 9London GM, Guerin AP, Marchais SJ, et al. Cardiac and arterial interactions in end-stage renal disease. Kidney Int, 1996,50: 600- 608.
  • 10O'Rourke MF, Hayward CS, Lehman ED. Arterial stiffness. In: Oparil S, Weber MA. Hypertension: a companion to Brenner & Rector's kidney. Philadelphia: WB Saunders, 2000:134-151.

共引文献12

同被引文献35

  • 1唐晓红,张艳玲,王莹莹.肾性高血压的诊治[J].现代临床医学,2011,37(5):382-385. 被引量:8
  • 2陈崴,王辉,董秀清,何惠娟,刘庆华,骆宁,谭嘉庆,林建雄,聂静,毛海萍,陈维清,余学清.广州市城区普通人群中慢性肾脏病的流行病学研究[J].中华肾脏病杂志,2007,23(3):147-151. 被引量:172
  • 3McCullough PA,Wolyn R,Rocher IX,et al.Acute renal failure after coronary intervention:incidence,risk factors,and relationship to mortality.Am J Med,1997,103:368-375.
  • 4Gibson CM,Pinto DS,Murphy SA,et al.TIMI Study Croup.Association of creatinine and creatinine clearance on presentation in acute myocardial infarction with subsequent mortality.J Am Coll Cardiol,2003,42:1535-1543.
  • 5Januzzi JL Jr,Snapinn SM,DiBattiste PM,et al.Benefits and safety of tirofiban among acute coronary syndrome patients with mild to moderate renal insufficiency:results from the platelet receptor inhibition in ischemic syndrome management in patients limited by unstable signs and symptoms (prism-plus) trial.Circulation,2002,105:2361-2366.
  • 6Newby LK,Bhapkar MV,White HD,et al.SYMPHONY and 2nd SYMPHONY Investigators.Predictors of 90-day outcome in patients stabilized after acute coronary syndromes.Heart J,2003,24:172-181.
  • 7Freeman RV,Mehta RH,Al Badr W,et al.Influence of concurrent renal dysfunction on outcomes of patients with acute coronary syndromes and implications of the use of glycoprotein Ⅱb/Ⅲa inhibitors.J Am Coll Cardiol,2003,41:718-724.
  • 8Blacher J,Guerin AP,Pannier B,et al.Impact of aortic stiffness on survival in end stage renal disease.Circulation,1999,99:2434-2439.
  • 9Foley RN,Parfby PS,Smak MJ.Clnical epidemiology of cardiovascular disease in chronic renal disease.Am J kidney Dis,1998,32 (5 Suppl 3):112-119.
  • 10Schillaci G,Pirro M,Mannarino MR,et al.Relation between renal function within the normal range and central and peripheral arterial stiffness in hypertension.Hypertension,2006,48:616-621.

引证文献5

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部